Comprehensive analysis and characterization of glycan pairing in therapeutic antibodies and Fc-containing biotherapeutics: Addressing current limitations and implications for N-glycan impact
- PMID: 38759899
- DOI: 10.1016/j.ejpb.2024.114325
Comprehensive analysis and characterization of glycan pairing in therapeutic antibodies and Fc-containing biotherapeutics: Addressing current limitations and implications for N-glycan impact
Abstract
N-glycosylation of the Fc part is a (critical) quality attribute of therapeutic antibodies and Fc-containing biotherapeutics, that impacts their stability, immunogenicity, pharmacokinetics, and effector functions. Current glycosylation analysis methods focus on the absolute amounts of glycans, neglecting the apparent glycan distribution over the entirety of proteins. The combination of the two Fc N-glycans, herein referred to as glyco-pair, therefore remains unknown, which is a major drawback for N-glycan impact assessment. This study presents a comprehensive workflow for the analysis and characterization of Fc N-glycan pairing in biotherapeutics, addressing the limitations of current glycosylation analysis methods. The applicability of the method across various biotherapeutic proteins including antibodies, bispecific antibody formats, and a Fc-Fusion protein is demonstrated, and the impact of method conditions on glycan pairing analysis is highlighted. Moreover, the influence of the molecular format, Fc backbone, production process, and cell line on glycan pairing pattern was investigated. The results underscore the significance of comprehensive glycan pairing analysis to accurately assess the impact of N-glycans on important product quality attributes of therapeutic antibodies and Fc-containing biotherapeutics.
Keywords: Biotherapeutic; Glycan pairing; Monoclonal antibody; N-glycosylation; Pharmacokinetics.
Copyright © 2024 The Authors. Published by Elsevier B.V. All rights reserved.
Conflict of interest statement
Declaration of competing interest The authors declare the following financial interests/personal relationships which may be considered as potential competing interests: Maximilian Meudt, Julia Baumeister, Michaela Blech and Fabian Higel are employees of Boehringer Ingelheim GmbH & Co. KG, which is developing, manufacturing, and marketing biopharmaceutical products.
Similar articles
-
Decoding the mannose receptor-mAb interaction: the importance of high-mannose N-glycans and glycan-pairing.MAbs. 2024 Jan-Dec;16(1):2400414. doi: 10.1080/19420862.2024.2400414. Epub 2024 Sep 8. MAbs. 2024. PMID: 39245969 Free PMC article.
-
N-glycans of complex glycosylated biopharmaceuticals and their impact on protein clearance.Eur J Pharm Biopharm. 2019 Jun;139:123-131. doi: 10.1016/j.ejpb.2019.03.018. Epub 2019 Mar 21. Eur J Pharm Biopharm. 2019. PMID: 30905778
-
Antibody glycosylation and its impact on the pharmacokinetics and pharmacodynamics of monoclonal antibodies and Fc-fusion proteins.J Pharm Sci. 2015 Jun;104(6):1866-1884. doi: 10.1002/jps.24444. Epub 2015 Apr 14. J Pharm Sci. 2015. PMID: 25872915 Review.
-
Fc glycan sialylation of biotherapeutic monoclonal antibodies has limited impact on antibody-dependent cellular cytotoxicity.FEBS Open Bio. 2021 Nov;11(11):2943-2949. doi: 10.1002/2211-5463.13267. Epub 2021 Oct 19. FEBS Open Bio. 2021. PMID: 34355537 Free PMC article.
-
Fc glycans of therapeutic antibodies as critical quality attributes.Glycobiology. 2015 Dec;25(12):1325-34. doi: 10.1093/glycob/cwv065. Epub 2015 Aug 11. Glycobiology. 2015. PMID: 26263923 Free PMC article. Review.
Cited by
-
Spotlight on Glycan Pairing: The Generation and Impact of Monoclonal Antibody Asymmetrical Fc N‑Glycan Pairs on Fc Receptor Interaction.ACS Pharmacol Transl Sci. 2025 May 21;8(6):1756-1767. doi: 10.1021/acsptsci.5c00185. eCollection 2025 Jun 13. ACS Pharmacol Transl Sci. 2025. PMID: 40534672
-
Decoding the mannose receptor-mAb interaction: the importance of high-mannose N-glycans and glycan-pairing.MAbs. 2024 Jan-Dec;16(1):2400414. doi: 10.1080/19420862.2024.2400414. Epub 2024 Sep 8. MAbs. 2024. PMID: 39245969 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources